Using targeted nanotherapy to prevent post-traumatic osteoarthritis after joint injuries
Targeted nanotherapy for the prevention of post-traumatic osteoarthritis
This study is looking at a new treatment using tiny particles to help prevent arthritis in people who have hurt their knees, especially those with ACL injuries, so they can keep their joints healthier and avoid needing surgery later on.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | St. Louis VA Medical Center NIH-funded |
| Lab location | 1 site (St. Louis, UNITED STATES) |
| Project ID | NIH-10911074 on NIH RePORTER |
What this research studies
This research investigates a novel approach using targeted nanotherapy to prevent the development of post-traumatic osteoarthritis (PTOA) in individuals who have suffered joint injuries, particularly those involving the anterior cruciate ligament (ACL). The study aims to understand how this therapy can modify the disease process and potentially halt the progression of arthritis that often follows such injuries. By focusing on the biological mechanisms involved in PTOA, the research seeks to identify effective treatments that could improve joint health and reduce the need for joint replacements in the future.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have experienced ACL injuries or similar joint trauma.
Not a fit: Patients who have not suffered any joint injuries or those with pre-existing osteoarthritis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly reduce the incidence of post-traumatic osteoarthritis, improving quality of life for patients with joint injuries.
How similar studies have performed: While the approach of using nanotherapy is innovative, similar research in the field of osteoarthritis treatment has shown promise, indicating potential for success.
Where this research is happening
St. Louis, UNITED STATES
- St. Louis VA Medical Center — St. Louis, United States (Active)
Researchers
- Principal investigator: Pham, Christine T. — St. Louis VA Medical Center
- Study coordinator: Pham, Christine T.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.